Source: Clinical Medicine Insights: Oncology. Unidade: FMRP
Subjects: LEUCEMIA (TRATAMENTO), ENZIMAS, QUIMIOTERÁPICOS, ANTINEOPLÁSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Augusto F. e BORGES, Kleiton S. e SILVEIRA, Vanessa da Silva. Update on the use of L-asparaginase in infants and adolescents patients with acute lymphoblastic leukemia. Clinical Medicine Insights: Oncology, v. 8, p. 95-100, 2014Tradução . . Disponível em: https://doi.org/10.4137/CMO.S10242. Acesso em: 15 jun. 2024.APA
Andrade, A. F., Borges, K. S., & Silveira, V. da S. (2014). Update on the use of L-asparaginase in infants and adolescents patients with acute lymphoblastic leukemia. Clinical Medicine Insights: Oncology, 8, 95-100. doi:10.4137/CMO.S10242NLM
Andrade AF, Borges KS, Silveira V da S. Update on the use of L-asparaginase in infants and adolescents patients with acute lymphoblastic leukemia [Internet]. Clinical Medicine Insights: Oncology. 2014 ; 8 95-100.[citado 2024 jun. 15 ] Available from: https://doi.org/10.4137/CMO.S10242Vancouver
Andrade AF, Borges KS, Silveira V da S. Update on the use of L-asparaginase in infants and adolescents patients with acute lymphoblastic leukemia [Internet]. Clinical Medicine Insights: Oncology. 2014 ; 8 95-100.[citado 2024 jun. 15 ] Available from: https://doi.org/10.4137/CMO.S10242
